DBS effectiveness against nonmotor features in PD is similar to those of infusion therapies. Capsule: DBS and infusion therapies are both recognized as therapeutic approaches in the treatment of motor symptoms in advanced stage PD when patients develop “wearing off” and/or dyskinesias with oral dopaminergic medication. However, the effects of these two therapeutic approaches on nonmotor features are still under debate, but seem to have similar beneficial effects.
When is the right time to refer PD patients for deep brain stimulation?
Clinical assessment in PD : Motor assessment is the key and nonmotor is not required No: Pedro Garcia Ruiz
Should untroubling dyskinesia be treated?
Should PD patients carrying (GBA) mutations be treated differently from gene negative?
Is continuous dopaminergic stimulation better strategy than pulsatile in every patient?
Is CSF alpha-snyuclein a useful biomarker for PD?
Are there important environmental factors for PD?
Clinical pathological conference (CPC)